无针给药设备市场规模预计将从 2023 年的 147.6 亿美元增至 2031 年的 284.2 亿美元。预计 2023-2031 年市场复合年增长率将达到 8.5%。战略举措的增加和医疗集成软件的使用可能仍是无针给药设备市场的主要趋势。
无针药物输送设备市场分析
如果不采取适当的预防措施,针头可能会导致各种疾病,例如艾滋病毒和伤害。根据文章“MEDICSEN:无针智能贴片,无痛给药”,美国每天有超过 2,000 人受到针刺伤害,每年产生超过 30 亿美元的相关费用。使用无针给药装置可降低这些伤害和疾病的发生几率。因此,针刺伤害患病率的激增和治疗费用的增加推动了无针给药装置市场的增长
无针药物输送设备市场概况
无针药物输送采用动力喷雾器、喷射注射器、吸入器和皮肤贴剂等形式。无针技术减少了患者对使用针头的担忧。无针装置可有效注射多种药物,且与针头生物等效。无针输送装置的优点包括疼痛少、注射快、无针头处理问题,并且可以自行给药。因此,无针药物输送装置相对于传统针头和注射器的优势是无针药物输送装置需求不断增长的主要原因。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
无针给药设备市场驱动因素和机遇
慢性病和生活方式紊乱患病率上升利好市场
心脏病、糖尿病和癌症等慢性疾病是全球死亡和残疾的主要原因。根据美国疾病控制和预防中心 (CDC) 的数据,2021 年美国约有 3840 万人患有糖尿病。为了控制糖尿病的发病率,需要定期通过皮下层注射胰岛素。由于糖尿病患病率的增加,对胰岛素注射的需求也在增长。这些公司正专注于开发无针胰岛素设备,以避免针刺伤。例如,Medicsen 正专注于开发 SmartPatch 以更有效地输送胰岛素。needlestick injuries. For instance, Medicsen is focusing on developing SmartPatch to deliver insulin with more efficacy.
家庭医疗保健需求日益增长——无针给药市场机遇
由于云和移动驱动的医疗设备的使用越来越多,从医院、长期设施、住院康复和专业护理机构转向家庭护理环境,患者和医生之间有更多机会进行更好、一致和及时的互动。在发展中国家,过去接受家庭治疗的患者数量有限。智能贴片和喷射注射器与电子健康记录 (EHR)EHR)集成,使医生可以随时随地监控剂量。借助无针给药装置,患者可以轻松地根据医生开具的要求自行给药。因此,在预测期内,对家庭医疗保健的关注度增加和技术集成产品的使用预计将成为市场增长的机会。
无针给药装置市场报告细分分析
有助于无针药物输送装置市场分析的关键部分是类型和应用。
- 根据类型,无针药物输送设备市场分为吸入器、喷射注射器、新型针头、透皮贴剂等。喷射注射器部分在 2023 年占据了最大的市场份额。
- 根据应用,市场分为胰岛素输送、疫苗接种、疼痛管理等。胰岛素输送疾病领域在 2023 年占据了市场主导地位。
无针药物输送设备市场份额(按地区)分析
无针给药装置市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲以及南美。
2023 年,北美占据无针药物输送设备市场的主导地位。北美市场的增长特点是生物制药和生物技术公司对罕见病药物的需求增加、主要市场参与者的存在、产品推出的增加、针刺伤负担的增加以及学术和研究机构以及制药和生物技术公司进行的广泛研发。此外,预计亚太地区将在未来几年录得最高的复合年增长率。
无针给药装置市场新闻和最新发展
无针药物输送设备市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是无针药物输送设备和策略市场发展列表:
- NovaXS 成立于加州大学伯克利分校,其正在申请专利的 Telosis 技术可在 0.3 秒内无需针头注射细流药物,并分析注射数据以做出更明智的健康决策。(来源:NovaXS Biotech,新闻稿,2022 年)
- NuGen Medical Devices Inc. 在加拿大推出了 InsuJet 设备。SOL-MILLENNIUM 医疗集团已注册为 2022 年加拿大糖尿病协会/加拿大内分泌和代谢学会 (CSEM) 专业会议的参展商,并在会上为加拿大推出了 InsuJet 产品。(来源:NuGen Medical Devices Inc,公司网站,2022 年)
无针药物输送设备市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响无针给药设备市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的无针给药设备市场细分和地理位置。
- 获取无针药物输送设备市场的区域特定数据
无针药物输送装置市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | 147.6亿美元 |
2031 年市场规模 | 284.2亿美元 |
全球复合年增长率(2023 - 2031) | 8.5% |
史料 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
无针给药设备市场参与者密度:了解其对业务动态的影响
无针给药设备市场正在快速增长,这得益于终端用户需求的不断增长,这些需求源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在无针药物输送设备市场运营的主要公司有:
- NuGen 医疗设备公司
- NovaXS 生物科技
- 葛兰素史克
- 阿斯利康
- 罗氏
- 勃林格殷格翰
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解无针药物输送设备市场主要参与者概况
无针给药装置市场报告覆盖范围和交付成果
“无针药物输送设备市场规模和预测(2023-2031)”报告对以下领域进行了详细的市场分析:
- 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
- 市场动态,如驱动因素、限制因素和关键机遇
- 未来主要趋势
- 详细的 PEST 和 SWOT 分析
- 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
- 详细的公司简介
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The needle-free drug delivery device market majorly consists of the players such NuGen Medical Devices Inc, NovaXS Biotech, GlaxoSmithKline, AstraZeneca, Roche, Boehringer Ingelheim, Merck, Cipla, Novartis, Teva Pharmaceuticals, Omron Healthcare, Sumitomo Pharma Co., Ltd
Needle-free drug deliveries are taken in the form of power sprays, jet injectors, inhalers, and skin patches. Needle-free technology reduces patient concern about using needles. Needle-free devices are effective injections for a wide range of drugs and are bioequivalent to needles. Advantages of needle-free delivery devices include less pain, fast injection, no needle disposal issue, and can be self-administered. Thus, the benefits of needle-free drug delivery devices over conventional needles and syringes are mainly responsible for the increasing demand for needle-free drug delivery devices.
Based on geography, the needle-free drug delivery device market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global needle-free drug delivery device market. Asia Pacific is expected to register the highest CAGR in the needle-free drug delivery device market during 2022–2030.
Based on type, the needle-free drug delivery devices market is segmented into inhalers, jet injectors, novel needles, transdermal patches, and others.
By application, the market is segmented into insulin delivery, vaccination, pain management, and others. The insulin delivery disease segment dominated the market in 2023.
Increasing prevalence of chronic diseases and increasing needlestick injuries propels the needle-free drug delivery devices market growth. However, the high cost of development as compare to injections hinders the growth of the market.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Needle-Free Drug Delivery Devices Market
- NuGen Medical Devices Inc
- NovaXS Biotech
- GlaxoSmithKline
- AstraZeneca
- Roche
- Boehringer Ingelheim
- Merck
- Cipla
- Novartis
- Teva Pharmaceuticals
- Omron Healthcare
- Sumitomo Pharma Co., Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.